BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28387606)

  • 1. Antimetabolites: Design, synthesis, and cytotoxic evaluation of novel dihydropyridine thioglycosides and pyridine thioglycosides.
    Elgemeie GH; Fathy NM; Farag AB; Alkursani SA
    Nucleosides Nucleotides Nucleic Acids; 2017 May; 36(5):355-377. PubMed ID: 28387606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, molecular docking and anti-hepatocellular carcinoma evaluation of novel acyclic pyridine thioglycosides.
    Elgemeie GH; Fathy NM; Farag AB; Alkhursani SA
    Nucleosides Nucleotides Nucleic Acids; 2018 Mar; 37(3):186-198. PubMed ID: 29608403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and in vitro anti-hepatocellular carcinoma of novel thymine thioglycoside analogs as new antimetabolic agents.
    Elgemeie GH; Farag AB
    Nucleosides Nucleotides Nucleic Acids; 2017 May; 36(5):328-342. PubMed ID: 28362220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel dihydropyridine thioglycosides and their corresponding dehydrogenated forms as potent anti-hepatocellular carcinoma agents.
    Elgemeie GH; El-Naggar DH
    Nucleosides Nucleotides Nucleic Acids; 2018; 37(4):199-216. PubMed ID: 29723119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antitumor activity of new dihydropyridine thioglycosides and their corresponding dehydrogenated forms.
    Abbas HA; El Sayed WA; Fathy NM
    Eur J Med Chem; 2010 Mar; 45(3):973-82. PubMed ID: 20004044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new class of antimetabolites: pyridine thioglycosides as potential anticancer agents.
    Elgemeie GH; Mahdy EM; Elgawish MA; Ahmed MM; Shousha WG; Eldin ME
    Z Naturforsch C J Biosci; 2010; 65(9-10):577-87. PubMed ID: 21138059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Nucleoside Analogues: First Synthesis of Pyridine-4-Thioglycosides and Their Cytotoxic Evaluation.
    Elgemeie G; Abou-Zeid M; Alsaid S; Hebishy A; Essa H
    Nucleosides Nucleotides Nucleic Acids; 2015; 34(10):659-73. PubMed ID: 26462063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Anticancer Activity of New 1-Thia-4-azaspiro[4.5]decane, Their Derived Thiazolopyrimidine and 1,3,4-Thiadiazole Thioglycosides.
    Flefel EM; El-Sayed WA; Mohamed AM; El-Sofany WI; Awad HM
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28117699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anticancer activity of new [(Indolyl)pyrazolyl]-1,3,4-oxadiazole thioglycosides and acyclic nucleoside analogs.
    El-Sayed WA; El-Sofany WI; Hussein HAR; Fathy NM
    Nucleosides Nucleotides Nucleic Acids; 2017 Jul; 36(7):474-495. PubMed ID: 28613111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Synthesis of 1,4-dihydropyridine Derivatives as Anti-cancer Agent.
    Viradiya D; Mirza S; Shaikh F; Kakadiya R; Rathod A; Jain N; Rawal R; Shah A
    Anticancer Agents Med Chem; 2017; 17(7):1003-1013. PubMed ID: 27924733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-hepatocellular carcinoma activity using human HepG2 cells and hepatotoxicity of 6-substituted methyl 3-aminothieno[3,2-b]pyridine-2-carboxylate derivatives: in vitro evaluation, cell cycle analysis and QSAR studies.
    Abreu RM; Ferreira IC; Calhelha RC; Lima RT; Vasconcelos MH; Adega F; Chaves R; Queiroz MJ
    Eur J Med Chem; 2011 Dec; 46(12):5800-6. PubMed ID: 22014996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of a new class of indeno[1,2-b]pyridine thioglycosides.
    Elgemeie GH; Fathy NM; Farag AB; Yahab AMB
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(8):1134-1149. PubMed ID: 32600173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in Vitro Anti-Tumor Activity of A New Class of Acyclic Thioglycosides.
    Elgemeie GH; Saber NM
    Nucleosides Nucleotides Nucleic Acids; 2015; 34(7):463-74. PubMed ID: 26158566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel purine thioglycoside analogs: synthesis, nanoformulation and biological evaluation in in vitro human liver and breast cancer models.
    Abu-Zaied MA; Loutfy SA; Hassan AE; Elgemeie GH
    Drug Des Devel Ther; 2019; 13():2437-2457. PubMed ID: 31440030
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and Cytotoxic Activity of New 1,3,4-Thiadiazole Thioglycosides and 1,2,3-Triazolyl-1,3,4-Thiadiazole
    Alminderej FM; Elganzory HH; El-Bayaa MN; Awad HM; El-Sayed WA
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31623291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 5-fatty-acylamido-1, 3, 4-thiadiazole-2-thioglycosides.
    Vudhgiri S; Koude D; Veeragoni DK; Misra S; Prasad RBN; Jala RCR
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3370-3373. PubMed ID: 28615134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate channeling between the human dihydrofolate reductase and thymidylate synthase.
    Wang N; McCammon JA
    Protein Sci; 2016 Jan; 25(1):79-86. PubMed ID: 26096018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of pyrrolo[2,3-b]pyridine analogues as antiproliferative agents and their interaction with calf thymus DNA.
    Narva S; Chitti S; Bala BR; Alvala M; Jain N; Kondapalli VG
    Eur J Med Chem; 2016 May; 114():220-31. PubMed ID: 26994690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological evaluation and molecular docking studies of some pyrimidine derivatives.
    Fargualy AM; Habib NS; Ismail KA; Hassan AM; Sarg MT
    Eur J Med Chem; 2013 Aug; 66():276-95. PubMed ID: 23811090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
    Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X
    Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.